1. Home
  2. XYL vs DXCM Comparison

XYL vs DXCM Comparison

Compare XYL & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XYL
  • DXCM
  • Stock Information
  • Founded
  • XYL 2011
  • DXCM 1999
  • Country
  • XYL United States
  • DXCM United States
  • Employees
  • XYL N/A
  • DXCM N/A
  • Industry
  • XYL Fluid Controls
  • DXCM Medical/Dental Instruments
  • Sector
  • XYL Industrials
  • DXCM Health Care
  • Exchange
  • XYL Nasdaq
  • DXCM Nasdaq
  • Market Cap
  • XYL 34.2B
  • DXCM 31.7B
  • IPO Year
  • XYL N/A
  • DXCM 2005
  • Fundamental
  • Price
  • XYL $141.89
  • DXCM $75.58
  • Analyst Decision
  • XYL Buy
  • DXCM Strong Buy
  • Analyst Count
  • XYL 9
  • DXCM 19
  • Target Price
  • XYL $150.75
  • DXCM $99.89
  • AVG Volume (30 Days)
  • XYL 1.1M
  • DXCM 4.1M
  • Earning Date
  • XYL 10-30-2025
  • DXCM 10-23-2025
  • Dividend Yield
  • XYL 1.13%
  • DXCM N/A
  • EPS Growth
  • XYL 21.62
  • DXCM N/A
  • EPS
  • XYL 3.84
  • DXCM 1.43
  • Revenue
  • XYL $8,730,000,000.00
  • DXCM $4,300,800,000.00
  • Revenue This Year
  • XYL $5.36
  • DXCM $17.03
  • Revenue Next Year
  • XYL $5.18
  • DXCM $15.59
  • P/E Ratio
  • XYL $37.00
  • DXCM $52.83
  • Revenue Growth
  • XYL 3.98
  • DXCM 9.30
  • 52 Week Low
  • XYL $100.48
  • DXCM $57.52
  • 52 Week High
  • XYL $145.33
  • DXCM $93.25
  • Technical
  • Relative Strength Index (RSI)
  • XYL 54.58
  • DXCM 41.15
  • Support Level
  • XYL $136.33
  • DXCM $75.39
  • Resistance Level
  • XYL $142.52
  • DXCM $81.64
  • Average True Range (ATR)
  • XYL 2.24
  • DXCM 2.29
  • MACD
  • XYL -0.32
  • DXCM -0.05
  • Stochastic Oscillator
  • XYL 65.35
  • DXCM 25.83

About XYL Xylem Inc. New

Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $8.6 billion in revenue in 2024.

About DXCM DexCom Inc.

DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

Share on Social Networks: